API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
EU WC
Listed Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-3-2024-41763.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2024-40984.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217087
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214640
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-9-2023-9584.pdf
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-tydemy-prescription-oral-contraceptive-may-have-reduced-effectiveness#:~:text=%5BAugust%201%2C%202023%5D%20FDA,an%20ingredient%2C%20in%20the%20product.
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-2-lots-tydemytm-drospirenone-ethinyl
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-2-lots-tydemytm-drospirenone-ethinyl
https://www.prnewswire.com/news-releases/lupin-pharmaceuticals-inc-issues-voluntary-nationwide-recall-of-2-lots-of-tydemytm-drospirenone-ethinyl-estradiol-and-levomefolate-calcium-tablets-3mg0-03mg0-451mg-and-levomefolate-calcium-tablets-0-451mg-due-to-out-of-spec-301888778.html
https://www.globenewswire.com/news-release/2023/06/26/2694408/30925/en/Agile-Therapeutics-Announces-the-Availability-of-Twirla-to-MMCAP-Infuse-Members.html
https://www.reuters.com/business/healthcare-pharmaceuticals/germanys-bayer-faces-shortage-contraceptive-pill-yasmin-india-2023-06-06/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212298
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207585
https://www.globenewswire.com/news-release/2022/10/07/2530548/30925/en/Agile-Therapeutics-Announces-Reorganization-of-Leadership-Team.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211328
https://www.expresspharma.in/glenmark-gets-us-fda-nod-for-norethindrone-acetate-and-ethinyl-estradiol-capsules-and-ferrous-fumarate-capsules-1-mg-20-mcg/
https://www.globenewswire.com/news-release/2022/01/10/2363993/30925/en/Agile-Therapeutics-and-Afaxys-Partner-to-Expand-Access-to-Twirla-Levonorgestrel-and-Ethinyl-Estradiol-Transdermal-System.html
https://www.expresspharma.in/lupin-recalls-4113-cartons-of-oral-contraceptive-medicine-in-us-market/
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-recalls-4113-cartons-of-oral-contraceptive-medicine-in-us-market/articleshow/88236402.cms
https://www.theguardian.com/australia-news/2021/oct/18/tga-dismisses-bid-to-make-contraceptive-pill-available-over-the-counter-in-australia
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-apotexs-mirvala-28-tablets-1633945878.pdf
https://www.globenewswire.com/news-release/2021/08/20/2284071/30925/en/Agile-Therapeutics-Partners-with-Telehealth-Service-Pandia-Health-to-Increase-Women-s-Access-to-Twirla-levonorgestrel-and-ethinyl-estradiol-transdermal-system.html
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75877r-eng.php
https://www.prnewswire.com/news-releases/slayback-pharma-announces-launch-of-merzee-norethindrone-acetate-and-ethinyl-estradiol-capsules-and-ferrous-fumarate-capsules-1-mg20-mcg-generic-equivalent-of-taytulla-301222104.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204305
https://www.globenewswire.com/news-release/2020/12/07/2140453/0/en/Agile-Therapeutics-Announces-Nationwide-Commercial-Launch-and-Availability-of-Twirla-levonorgestrel-and-ethinyl-estradiol-Transdermal-System-a-New-Non-Daily-Non-Invasive-Contracept.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091692
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207033
https://www.businesswire.com/news/home/20200909005861/en/TherapeuticsMD-Announces-Patent-Updates-ANNOVERA%C2%AE
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207065
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-19-2020-1597808962.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202962
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210087
https://www.globenewswire.com/news-release/2020/01/02/1965657/0/en/Agile-Therapeutics-Strengthens-Commercial-Leadership-Team.html
https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-usfda-nod-for-contraceptive-tablets/70799219
https://health.economictimes.indiatimes.com/news/pharma/glenmark-gets-usfda-nod-for-contraceptive-tablets/70799219
https://www.in-pharmatechnologist.com/Article/2019/08/06/Jubilant-recalls-contraceptives
https://www.pharmacompass.com/pdf/news/jubilant-cadista-issues-voluntary-nationwide-recall-of-drospirenone-and-ethinyl-estradiol-tablets-usp-1564083915.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-3-2019-1554267295.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211944
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-13-2019-1552453797.pdf
https://www.pharmacompass.com/pdf/news/apotex-corp-issues-recalls-of-drospirenone-and-ethinyl-estradiol-tablets-1551769735.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209548
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202988
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-14-2018-1542217134.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-24-2018-1540357479.pdf
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-15-18-october-2018